October 9, 2020: The Week in Cancer News
A study finds that more than half of cancer patients participate in clinical trials when asked.
Progress Against Cancer
A study finds that more than half of cancer patients participate in clinical trials when asked.
A new study reports that an inexpensive way to analyze DNA isolated from cells in urine is more sensitive than urine cytology, a microscopic examination of cells in the urine. When a doctor suspects...
A study of 1.7 million women finds that HPV vaccination reduces the rate of cervical cancer.
The FDA approved a combination of two immune checkpoint inhibitors to treat adult patients with unresectable malignant pleural mesothelioma.
Long-term social and economic factors contribute to disparities in cancer mortality in U.S. counties with "persistent poverty".
Neoadjuvant therapy—using treatments to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer.
A therapeutic vaccine targeting advanced cervical cancer.
Fear of discrimination may lead to lower screening rates.
The Clinical Treatment Act aims to include more Medicaid recipients.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More